Work

Abstract 6034: Development of a pan-HLA-A02 restricted AFP targeting TCR for both TCR-T and TCR-bispecific therapy

Year: 2025
Type: conference-abstract
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4409643312
Cites:
Cited by:
Related to: 10